
doi: 10.1007/bf02233474
pmid: 13302190
A group of patients were studied while taking phenmetrazine and a placebo, the dietary prescription having been kept constant, using the double blind procedure. The same patients were observed while taking each preparation, thus allowing each one to serve as her own control. The rate of loss of weight while taking phenmetrazine was more than twice that observed when a placebo was used. No significant effects upon the blood pressure, pulse rate, hemoglobin, white blood count, urinalysis, or basal metabolic rate were noted. Side effects while taking phenmetrazine were only slightly more frequent than during placebo medication.
Disease Management, Obesity, Sympathomimetics, Phenmetrazine
Disease Management, Obesity, Sympathomimetics, Phenmetrazine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 23 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
